BUZZ-U.S. STOCKS ON THE MOVE-Spotify, Robinhood Markets, Cannabis stocks

BUZZ-U.S. STOCKS ON THE MOVE-Jabil, Texas Pacific Land, Texas Roadhouse

BUZZ-J.P.Morgan sees brighter outlook for US healthcare services in 2026

Labor Smart Inc. Announces Strategic Portfolio Alignment to Focus on Core Brands, National Adios® Rollout, and Expansion of B2B Distribution via Cencora Platform

Cencora Inc. Stock Outperforms Competitors On Strong Trading Day

Evercore ISI Adjusts Price Target on Cencora to $420 From $400, Maintains Outperform Rating

Cencora Signs Deal to Acquire Majority Equity Interest in OneOncology, Updates Outlook

Cencora to Acquire TPG’s Stake in OneOncology

Cencora Finalizes Agreement to Acquire TPG's Equity Interest in Oneoncology

Cencora to take majority control of OneOncology

Cencora - in Anticipation of Company's Acquisition of Oneoncology, It Is Pausing Share Repurchases

Cencora - Sees Long-Term Adjusted Diluted Earnings per Share up 10% to 14%

Cencora - to Fund Deal With New Debt Financing

Cencora Outlook FY Adjusted EPS USD 17.45-17.75

Cencora - to Buy Stake in Oneoncology for $3.6 Bln

Cencora - Expects Deal to Be About Neutral, Net of Financing Costs, to Co's Adjusted Diluted EPS in First Twelve Months Following Close

Cencora - More Likely Company's Full Year Adjusted Diluted EPS Will Be Towards Lower Half of Its Guidance Range of $17.45 to $17.75

Cencora Outlook Long-Term Adjusted Operating Income 7% to 10%